5871 OBERLIN DRIVE, SUITE 200, SAN DIEGO, CA
ADARx Pharmaceuticals Enters $100M Common Stock Purchase Agreement with AbbVie
No filings found
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(4)
Certificate
Effectiveness Notice
Registration of Securities
Amended Registration Statement for Securities
S-1
Schedule 13D - Ownership Report
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
S-1MEF